Carlos Trujillo
Directeur Financier/CFO chez PHARMACYTE BIOTECH, INC.
Fortune : 22 048 $ au 30/04/2024
Postes actifs de Carlos Trujillo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PHARMACYTE BIOTECH, INC. | Directeur Financier/CFO | 01/03/2017 | - |
| Directeur/Membre du Conseil | 01/03/2017 | 15/08/2022 |
Historique de carrière de Carlos Trujillo
Anciens postes connus de Carlos Trujillo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VELATEL GLOBAL COMMUNICATIONS INC | Directeur Financier/CFO | 01/06/2008 | 01/09/2014 |
| California Cove Communities, Inc. | Directeur Financier/CFO | 01/01/2008 | 01/01/2008 |
Viridis Biotech, Inc.
 Viridis Biotech, Inc. Pharmaceuticals: MajorHealth Technology Part of PharmaCyte Biotech, Inc., Viridis Biotech, Inc. develops biopharmaceutical products for the treatment of chronic diseases. The company is based in Silver Spring, MD. The CEO of the company is Timothy M. Matula. | Directeur Financier/CFO | 01/01/2015 | - |
Formation de Carlos Trujillo
| California State University-Fullerton | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Director of Finance/CFO | 4 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 3 |
| Communications | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHARMACYTE BIOTECH, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
VelaTel Global Communications, Inc.
 VelaTel Global Communications, Inc. Specialty TelecommunicationsCommunications VelaTel Global Communications, Inc. provides capital, engineering, architectural and construction services related to the build-out of wireless broadband telecommunications networks, which it then operates by offering services attractive to residential, enterprise and government subscribers. Its focus is on the deployment of telecommunications networks that utilize Wireless Broadband Access in emerging international markets. The company was founded on September 19, 2005 and is headquartered in Carlsbad, CA. | Communications |
| California Cove Communities, Inc. | |
Viridis Biotech, Inc.
Viridis Biotech, Inc. Pharmaceuticals: MajorHealth Technology Part of PharmaCyte Biotech, Inc., Viridis Biotech, Inc. develops biopharmaceutical products for the treatment of chronic diseases. The company is based in Silver Spring, MD. The CEO of the company is Timothy M. Matula. | Health Technology |
- Bourse
- Insiders
- Carlos Trujillo
- Expérience